RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, will display a poster at 10:45AM on Tuesday May 19th at the 109th General Meeting of the American Society of Microbiology. The poster will describe the latest information on the mechanism of action of PolyMedix arylamide foldamers.
